Australia's largest stock trading and investment forum Australia's #1 stock forum

API

Click for more information

0.74%

$1.35 australian pharmaceutical industries limited

Highly undervalued, page-22

First 22 Last

Share
Profile

Follow
Lara

1,079 Posts.

2

03/08/17

15:47

Post #: 26271048
Share

Originally posted by joonies ↑

Yep think people seem to be missing this.

NPAT $51.7M FY16, so looking like $53.6M or so in FY17, as opposed to minimum NPAT of $56.2M originally forecast.

The SP this time last year was around $1.90. Making more profit, just didnt hit expectations. SP now at $1.55 which I just bought in at. MC is now around $760M or so compared to $868M last year? Still doing well against peers, so think this is pretty cheap atm

Expand

Understand but H2 will only show a run rate of say $24m. Multiply that by 2 and you get a run rate of say $48m

API Price at posting: $1.52 Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

AXP

Tambourah chases gold veins and mineralisation extension with drilling

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

There are more pages in this discussion • 51 more messages in this thread...

First 22 Last

Add API (ASX) to my watchlist

SPONSORED BY